Et sed illum sapienteEt sed illum sapiente.. Labore qui expedita aut consectetur assumenda sed. Aliquid soluta quae est debitis esse velit quod dolor. Quasi tenetur … 4 weeks ago By John In Research Updates
Vertex and CRISPR Therapeutics Secure First-Ever FDA Approval for CRISPR-Based Therapy in Sickle Cell Disease In a historic milestone for genetic medicine, the FDA has approved Casgevy—a CRISPR-based gene-editing therapy developed by Vertex … 8 months ago By John In Biopharma Highlights,FDA Approvals,Research Updates,Top Stories,